ICU Medical Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
314
309
340
379
1,293
1,400
Cost of Goods Sold (COGS) incl. D&A
159
158
161
178
867
831
Gross Income
155
151
179
201
425
569
SG&A Expense
103
107
97
102
355
373
EBIT
52
44
82
99
70
196
Unusual Expense
-
5
14
16
86
167
Non Operating Income/Expense
-
1
2
1
69
11
Interest Expense
-
-
-
-
2
1
Pretax Income
53
40
70
85
51
22
Income Tax
12
13
25
22
17
6
Consolidated Net Income
40
26
45
63
69
29
Net Income
40
26
45
63
69
29
Net Income After Extraordinaries
40
26
45
63
69
29
Net Income Available to Common
40
26
45
63
69
29
EPS (Basic)
2.65
1.68
2.73
3.66
3.29
1.33
Basic Shares Outstanding
15
15
16
16
20
20
EPS (Diluted)
2.65
1.68
2.73
3.66
3.29
1.33
Diluted Shares Outstanding
15
16
16
17
21
22
EBITDA
71
64
100
118
137
271
Non-Operating Interest Income
-
-
1
1
-
5

About ICU Medical

View Profile
Address
951 Calle Amanecer
San Clemente California 92673
United States
Employees -
Website http://www.icumed.com
Updated 07/08/2019
ICU Medical, Inc. is an infusion therapy company, which engages in the development, manufacturing and sale of innovative medical devices used in vascular therapy and critical care applications. The company's product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors designed to help meet clinical, safety and workflow goals. Its customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as clinics, home health care providers and long-term care facilities.